ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0201

Use of Infrared Thermography for Expedited Rheumatology Referral in a Primary Care Center

Giovanna Rosas chavez1, Kiara Aaron2, Jeffrey Curtis3, Rahima Begum4, Laura Hughes4, Brianna Holder4 and Maria I. ("Maio") Danila5, 1University of Alabama at Birmingham, Hoover, AL, 2University of Alabama at Birmingham (UAB), Birmingham, AL, 3The University of Alabama at Birmingham, Birmingham, AL, 4University of Alabama at Birmingham, Birmingham, AL, 5University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL

Meeting: ACR Convergence 2024

Keywords: Autoinflammatory diseases, Health Services Research, Imaging

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Health Services Research – ACR/ARP Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Infrared thermography (IRT) can detect joint inflammation in people with suspected inflammatory joint symptoms. Thus, IRT could be a helpful tool to assess joint pain in different clinical settings including primary care. We conducted a feasibility study to assess the use of IRT in the primary care clinic setting as a triage tool for the assessment of inflammatory arthritis in patients presenting with joint pain for the purpose of expediting rheumatology referral. 

Methods: Eligible patients in this study were age >18 years, had prior/current wrist/hand/feet pain within the last 6 months (documented by PCP); patients previously seen by a rheumatologist were excluded. Using a previously established approach, IRT images from wrists/MCPs were obtained using a FLIR E75 3400 camera . A manual segmentation approach was employed on the images analyzed. (Figure 1) FLIR software was used to determine IRT temperature (°C) parameters including ROI maximum (max), minimum (min), mean (mean), center (center) and within-joint variability (STD). We previously established cut-off points for T mean and T center measurements based on  ROC-AUC values using a logistic regression model to discriminate inflamed joints (power Doppler >1 on musculoskeletal ultrasound). Patients with temperatures above the cut off values (T center) for wrist and MCPs were referred. Electronic medical records reviewed following rheumatology visit on all recruited participants and information on rheumatology diagnosis as well as inflammatory and autoimmunity markers (e.g. CRP, ANA, RF, anti-CCP) were extracted. Descriptive statistics were used.

Results: A total of 20 patients were approached at their primary care visits between July 2023 and April 2024 with joint pain. Mean(SD) time required to obtain IRT images in the primary care visit was 6.9(1.5) minutes. Out of these, 10 patients met criteria based on T center values for MCPs and wrist (MCP: T center >32.93°C; wrist: T center >33.73°C) for rheumatology referral and were scheduled in the rheumatology clinic. Baseline characteristics of these patients that were referred to rheumatology vs not referred were: mean age (SD) 57.7(14.6) vs 58.8(13) years, female sex (%) 50 vs 70. (Table 1) Temperatures (SD) in both groups (referred vs not referred): T center MCP 33.8°C(1.1) vs 29.9°C(1.4) and T center wrist 33.8°C(0.8) vs 31.1°C(0.9). Eight out of ten referred were able to see a rheumatologist within 4 weeks after their PCP visit. Inflammatory markers in both groups were similar (referred vs not referred): ESR (17 vs 31.4 [normal 0-20 mm/hr]), CRP (13.5 vs 12.5 [normal 0-10.9 mg/L]). Only one patient had a positive RF (18) but no definite rheumatoid arthritis diagnosis.  After rheumatology evaluation, 6 patients were diagnosed with osteoarthritis, 1 patient diagnosed with gout and 1 patient diagnosed with CPPD.

Conclusion: Thermography can be efficiently implemented during a primary care visit and could serve as an additional tool to improve clinicians’ confidence in the appropriateness of rheumatology referral. However, additional studies with larger sample sizes need to be conducted to optimize IRT utilization and thresholds to trigger referral and triage its appropriate timing. 

Supporting image 1

*Patients with Raynaud’s excluded

Supporting image 2

Figure 1. Manual segmentation approach of thermography images


Disclosures: G. Rosas chavez: None; K. Aaron: None; J. Curtis: AbbVie, 2, 5, Amgen, 2, 5, AstraZeneca, 2, 5, Bendcare, 2, 5, Eli Lilly, 2, 5, Genentech, 2, 5, GlaxoSmithKline, 2, 5, Horizon, 2, 5, Janssen, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Sanofi, 2, 5, Scipher Medicine, 2, 5, Setpoint, 2, 5, UCB Pharma, 2, 5; R. Begum: None; L. Hughes: None; B. Holder: None; M. Danila: AbbVie/Abbott, 2, Pfizer, 5.

To cite this abstract in AMA style:

Rosas chavez G, Aaron K, Curtis J, Begum R, Hughes L, Holder B, Danila M. Use of Infrared Thermography for Expedited Rheumatology Referral in a Primary Care Center [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/use-of-infrared-thermography-for-expedited-rheumatology-referral-in-a-primary-care-center/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/use-of-infrared-thermography-for-expedited-rheumatology-referral-in-a-primary-care-center/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology